SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab

Qingyun Yang,1,&ast; Tingkai Xiang,1,&ast; Yangfan Wu,1,&ast; Enyi Ye,1,&ast; Beilei He,1,&ast; Zhangyu Bu2,&ast; 1Department of The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310006 People’s Republic of China; 2Department of...

Full description

Bibliographic Details
Published in:	Clinical, Cosmetic and Investigational Dermatology
Main Authors:	Yang Q, Xiang T, Wu Y, Ye E, He B, Bu Z
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-11-01
Subjects:	synovitis acne psoriasis bone hypertrophy osteitis psoriasis arthritis adalimumab.
Online Access:	https://www.dovepress.com/sapho-syndrome-with-palmoplantar-pustulosis-as-the-first-manifestation-peer-reviewed-fulltext-article-CCID

Similar Items

Desafios no diagnóstico e tratamento de um caso de síndrome SAPHO na infância Challenges in diagnosis and treatment of a case of SAPHO syndrome in
by: Patricia Craveiro Gomes da Silva, et al.
Published: (2011-08-01)

Zespół SAPHO jako wyzwanie terapeutyczne – opis przypadku
by: Grażyna Chodorowska, et al.
Published: (2011-11-01)

Adalimumab-Induced Erythrodermic Psoriasis Associated with Alopecia in a Patient with Palmoplantar Pustulosis
by: Ying Wang, et al.
Published: (2024-04-01)

A Bull’s Head Sign in SAPHO
by: Firdevs Ulutaş, et al.
Published: (2023-02-01)

SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report
by: Michele Luzzati, et al.
Published: (2020-11-01)

Unilateral Verrucous Psoriasis Successfully Treated With Adalimumab
by: Artur Antônio Duarte, et al.
Published: (2024-01-01)

Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome and Paradoxical Psoriasis with Secukinumab: A Case Report
by: Fan D, et al.
Published: (2024-03-01)

A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week)
by: Yuki Nanke, et al.
Published: (2019-04-01)

Sapho syndrome. Tune-up on a clinical case in the CHPR.
by: Juan Miguel Del Castillo Bellón, et al.
Published: (2018-02-01)

SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis); A Case of Backache in an Adolescent in Pakistan
by: Abdul Rehman Azeem Dar, et al.
Published: (2023-12-01)

THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01)

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab
by: Angela Fico, et al.
Published: (2025-05-01)

Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis
by: Esra Yıldırım Bay, et al.
Published: (2021-06-01)

Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan
by: Pei-Han Kao, et al.
Published: (2015-09-01)

Adalimumab
by: Nilgun Atakan
Published: (2022-04-01)

Adalimumab induced psoriasis in a Crohn’s disease patient: a case report
by: Dhaifallah Alrakawi Alenizi
Published: (2024-06-01)

A Case of Lip Psoriasis in a 14-Year-Old Boy Successfully Treated with Adalimumab
by: Francesca Caroppo, et al.
Published: (2023-09-01)

A case of synovitis-acne-pustulosis-hyperostosis-osteitis syndrome with right pleural effusion
by: Takayuki Kakimoto, et al.
Published: (2023-01-01)

Adalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis
by: Savas Yayli, et al.
Published: (2013-11-01)

Lithium-Associated Generalized Ostraceous Psoriasis Treated with Adalimumab: A Case Report
by: Yang Y, et al.
Published: (2023-04-01)

Postpartum lumbopelvic pain could be SAPHO syndrome: a case report
by: Zheng Weiwei, et al.
Published: (2025-08-01)

SAPHO
by: Viviana Parra Izquierdo, et al.
Published: (2018-03-01)

Síndrome Sapho: reporte de caso
by: Anghelina Villar, et al.
Published: (2019-12-01)

Efficacy and Safety of Adalimumab and Secukinumab in Erythrodermic Psoriasis: A Single Centre Retrospective Study
by: Yachen Wang, et al.
Published: (2025-07-01)

Summary of Research: Immunogenicity of Adalimumab Reference Product and Adalimumab-adbm in Patients with Rheumatoid Arthritis, Crohn’s Disease, and Chronic Plaque Psoriasis: A Pooled Analysis of the VOLTAIRE trials
by: Vibeke Strand
Published: (2025-06-01)

Efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis
by: Zhanhan TANG, et al.
Published: (2023-04-01)

More than skin‐deep elbow pain in a psoriatic arthritis patient after phlebotomy
by: Ikwinder Preet Kaur, et al.
Published: (2024-04-01)

Onychoscopy in Palmoplantar Psoriasis: A Comparative Study of Nonpustular Palmoplantar Psoriasis and Palmoplantar Pustulosis
by: Ahu Yorulmaz
Published: (2024-10-01)

Commentary: Successful treatment of refractory palmoplantar pustular psoriasis with apremilast: a case series
by: Madison Hackley, et al.
Published: (2023-10-01)

Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab
by: Blauvelt A, et al.
Published: (2020-03-01)

Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
by: Xu Q, et al.
Published: (2023-08-01)

The value of multi-modality imaging in establishing the diagnosis of Adolescent SAPHO
by: Sudarshan Ravi, BMed, MD, et al.
Published: (2022-04-01)

Transition from secukinumab to adalimumab in COVID‐19‐induced psoriasis flare‐up treatment: A case report
by: Yuting Chen, et al.
Published: (2023-10-01)

Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
by: Ting-Shun Wang, et al.
Published: (2013-03-01)

Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
by: Changkun Li, et al.
Published: (2023-12-01)

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy
by: Marco May Lee, et al.
Published: (2025-07-01)

MANAGEMENT OF A PATIENT WITH SEVERE COURSE OF PSORIATIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-05-01)

Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H trial
by: Kristian Reich, et al.
Published: (2022-05-01)

Eosinophilia Induced by Biosimilar Adalimumab (CinnoRA) in a Patient with Psoriasis and Psoriatic Arthritis: A Case Report
by: Saedpanah R, et al.
Published: (2025-09-01)

Comparative efficacy and safety of adalimumab biosimilar (BCD-057) and innovator in patients with psoriasis vulgaris. Results of the BCD-057-2/CALYPSO phase III international, multicenter, randomized double-blind clinical trial
by: Т. V. Korotaeva, et al.
Published: (2018-12-01)